221 related articles for article (PubMed ID: 10491376)
1. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.
Cooper HA; Dries DL; Davis CE; Shen YL; Domanski MJ
Circulation; 1999 Sep; 100(12):1311-5. PubMed ID: 10491376
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.
Dries DL; Exner DV; Gersh BJ; Domanski MJ; Waclawiw MA; Stevenson LW
J Am Coll Cardiol; 1998 Sep; 32(3):695-703. PubMed ID: 9741514
[TBL] [Abstract][Full Text] [Related]
3. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).
Domanski M; Norman J; Pitt B; Haigney M; Hanlon S; Peyster E;
J Am Coll Cardiol; 2003 Aug; 42(4):705-8. PubMed ID: 12932605
[TBL] [Abstract][Full Text] [Related]
4. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction.
Merlo M; Gentile P; Artico J; Cannatà A; Paldino A; De Angelis G; Barbati G; Alonge M; Gigli M; Pinamonti B; Ramani F; Zecchin M; Pirozzi F; Stolfo D; Sinagra G
J Cardiovasc Med (Hagerstown); 2019 May; 20(5):343-350. PubMed ID: 30921270
[TBL] [Abstract][Full Text] [Related]
6. Non-potassium-sparing diuretics and risk of sudden cardiac death.
Grobbee DE; Hoes AW
J Hypertens; 1995 Dec; 13(12 Pt 2):1539-45. PubMed ID: 8903607
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
de Denus S; Tardif JC; White M; Bourassa MG; Racine N; Levesque S; Ducharme A
Am Heart J; 2006 Oct; 152(4):705-12. PubMed ID: 16996842
[TBL] [Abstract][Full Text] [Related]
8. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
[TBL] [Abstract][Full Text] [Related]
9. Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop/potassium sparing diuretic combinations.
Johnston RT; de Bono DP; Nyman CR
Int J Cardiol; 1992 Feb; 34(2):213-5. PubMed ID: 1737674
[TBL] [Abstract][Full Text] [Related]
10. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction.
Cooper HA; Exner DV; Domanski MJ
J Am Coll Cardiol; 2000 Jun; 35(7):1753-9. PubMed ID: 10841221
[TBL] [Abstract][Full Text] [Related]
11. Diuretic use, progressive heart failure, and death in patients in SOLVD.
Ghali JK
J Am Coll Cardiol; 2004 May; 43(9):1723; author reply 1723. PubMed ID: 15120837
[No Abstract] [Full Text] [Related]
12. Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence.
Hoes AW; Grobbee DE; Peet TM; Lubsen J
Drugs; 1994 May; 47(5):711-33. PubMed ID: 7520854
[TBL] [Abstract][Full Text] [Related]
13. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
Parker AB; Yusuf S; Naylor CD
Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
[TBL] [Abstract][Full Text] [Related]
14. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
[TBL] [Abstract][Full Text] [Related]
15. Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis.
Kuller LH; Hulley SB; Cohen JD; Neaton J
Circulation; 1986 Jan; 73(1):114-23. PubMed ID: 2416486
[TBL] [Abstract][Full Text] [Related]
16. Diuretic-induced hypokalaemia and ventricular arrhythmias.
Holland OB
Drugs; 1984 Oct; 28 Suppl 1():86-92. PubMed ID: 6499705
[TBL] [Abstract][Full Text] [Related]
17. Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial.
Cohen JD; Neaton JD; Prineas RJ; Daniels KA
Am J Cardiol; 1987 Sep; 60(7):548-54. PubMed ID: 2442992
[TBL] [Abstract][Full Text] [Related]
18. Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.
van Kraaij DJ; Jansen RW; Gribnau FW; Hoefnagels WH
Drugs Aging; 2000 Apr; 16(4):289-300. PubMed ID: 10874524
[TBL] [Abstract][Full Text] [Related]
19. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction.
Hartikainen JE; Malik M; Staunton A; Poloniecki J; Camm AJ
J Am Coll Cardiol; 1996 Aug; 28(2):296-304. PubMed ID: 8800101
[TBL] [Abstract][Full Text] [Related]
20. Potassium loss, ventricular irritability, and the risk of sudden death in hypertensive patients.
Holland OB
Drugs; 1986; 31 Suppl 4():78-84. PubMed ID: 3732099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
